Azitra, Inc. reported on June 17, 2025, safety data from its initial clinical trial for ATR-12, a treatment for Netherton syndrome. The filing includes a press release for further details.
AI Assistant
AZITRA INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.